Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

13 Oct 2021 07:00

RNS Number : 8661O
Centaur Media PLC
13 October 2021
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

 

13 October 2021

Centaur Media Plc

("Centaur" or the "Company")

Trading Update & Capital Markets Day

Centaur Media Plc, an international provider of business information, training and specialist consultancy, is pleased to announce an update on trading for the period ended 30 September 2021 and its outlook for the full year. The Company is also hosting its 2021 Capital Markets Day today.

 

Trading Update

 

Since the publication of the Company's Interim Results on 21 July 2021, the Board is pleased to announce that Centaur has continued to experience strong trading conditions enabling it to grow its revenues and adjusted1 EBITDA across both Xeim and The Lawyer.

 

Centaur's Brands continue to perform in line with its Margin Acceleration Plan (MAP23) objectives, notably:

 

Econsultancy is seeing subscriptions outperform management expectations, mainly through a sustained level of new business wins and demand for its blended learning proposition. Delivery of its training offering is on track.

The Marketing Week Mini MBA had another period of high double-digit growth driven by increased delegate numbers and price increases.

Influencer Intelligence is recovering as its new business and renewal rates are starting to rise following the significant impact of Covid on its smaller PR and fashion customers.

The Lawyer is ahead of target on corporate renewal rates, while billings are on track for its new Signal product, a subscription service offering in-depth strategic insight and benchmarking of markets, clients and competitors. Recruitment advertising has shown a strong recovery since 2020.

 

Next week, Centaur will be hosting the pinnacle in its events calendar, the Festival of Marketing: The Year Ahead. The four-day virtual event with live Q&As and video-on-demand will feature over 80 speakers, including the senior marketing leaders of several high profile brands such as Mastercard, Tesco, Coca-Cola, Diageo and Virgin, who will be joined by leading marketing academics Byron Sharp and Mark Ritson, as well as John Cleese, Eddie Izzard and Richard Curtis. The Lawyer is also hosting a number of events in Q4 including next week's hybrid In-House Counsel as Business Partner and next month's The Lawyer Awards.

 

Centaur's net cash balance stood at £12.4m as at 30 September 2021 (£11.9m as at 30 June 2021).

 

2021 Full Year Outlook

 

The Board expects full-year revenues to exceed £37m, a 15% year-on-year increase and at the top end of market expectations. Margins in H2 2021 continue to improve, with adjusted1 EBITDA margin for FY 2021 expected to be approximately 15%.

 

Xeim, our business unit serving the marketing sector, is expected to report a year-on-year underlying revenue increase of at least 17% with The Lawyer expecting to report an underlying revenue increase of at least 7%.

 

The Board remains confident in the successful delivery of Centaur's revenue and EBITDA margin objectives as set out under MAP23.

 

Capital Markets Day

 

Centaur will today hold a Capital Markets Day for institutional investors and analysts. The event will be hosted by Swag Mukerji, CEO, and Simon Longfield, CFO, together with a number of the senior management team from across the Company.

 

The Capital Markets Day will cover Centaur's strategic progress, while providing further detail on its Flagship 4 and Core Brands and outlining the role of these brands within the Company's MAP23 strategy.

 

The presentations will commence at 10:00 BST. A recording will subsequently be made available on the Company's website.

 

No further trading information will be disclosed during the event.

 

1 Adjusted EBITDA is adjusted operating profit before depreciation and amortisation on a post-IFRS 16 basis. Adjusted results exclude adjusting items, such as exceptional items, as detailed in note 4 of the Interim Report for the period ended 30 June 2021.

 

Enquiries

Centaur Media Plc

020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

Teneo

Zoë Watt / Matthew Thomlinson

07713 157561 / 07785 528363

Note to editors

Centaur is an international provider of business information, training and specialist consultancy that inspires and enables people to excel at what they do, raising the standard for insight, interaction and impact.  Leading brands include The Lawyer, Econsultancy, Influencer Intelligence, MW Mini MBA, Marketing Week, Festival of Marketing, Creative Review, Fashion & Beauty Monitor, Oystercatchers and Really B2B.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUAKRANURAAA
Date   Source Headline
29th Mar 20187:00 amRNSTotal Voting Rights
22nd Mar 201811:17 amRNSDirector/PDMR Shareholding
21st Mar 20181:18 pmRNSDirector/PDMR Shareholding
21st Mar 201812:24 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSFinal Results
28th Feb 20187:00 amRNSTotal Voting Rights
26th Feb 20183:44 pmRNSHolding(s) in Company
21st Feb 20187:00 amRNSDirector/PDMR Shareholding
8th Feb 20183:35 pmRNSHolding(s) in Company
7th Feb 201810:39 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSTotal Voting Rights
25th Jan 20183:36 pmRNSHolding(s) in Company
24th Jan 20187:00 amRNSTrading Update
22nd Jan 20183:30 pmRNSDirector/PDMR Shareholding
10th Jan 201810:23 amRNSHolding(s) in Company
10th Jan 201810:16 amRNSHolding(s) in Company
29th Dec 201711:54 amRNSTransaction in Own Shares
29th Dec 20177:00 amRNSTotal Voting Rights
21st Dec 20175:57 pmRNSTransaction in Own Shares
20th Dec 20172:01 pmRNSDirector/PDMR Shareholding
13th Dec 20177:00 amRNSTransaction in Own Shares
12th Dec 20177:00 amRNSAppointment of Chairman and Trading Update
12th Dec 20177:00 amRNSTransaction in Own Shares
1st Dec 20177:00 amRNSTransaction in Own Shares
30th Nov 201710:30 amRNSTotal Voting Rights
21st Nov 20173:42 pmRNSDirector/PDMR Shareholding
3rd Nov 20177:00 amRNSTransaction in Own Shares
31st Oct 20177:00 amRNSTotal Voting Rights
20th Oct 20171:14 pmRNSHolding(s) in Company
19th Oct 20172:33 pmRNSDirector/PDMR Shareholding
19th Oct 20177:00 amRNSTransaction in Own Shares
13th Oct 20177:00 amRNSTransaction in Own Shares
10th Oct 20177:00 amRNSTransaction in Own Shares
6th Oct 20177:00 amRNSTransaction in Own Shares
2nd Oct 201710:45 amRNSTotal Voting Rights
28th Sep 20177:00 amRNSTransaction in Own Shares
20th Sep 20177:00 amRNSDirector/PDMR Shareholding
20th Sep 20177:00 amRNSTransaction in Own Shares
15th Sep 20177:00 amRNSTransaction in Own Shares
12th Sep 20177:00 amRNSTransaction in Own Shares
1st Sep 20179:12 amRNSTotal Voting Rights
30th Aug 20177:00 amRNSTransaction in Own Shares
22nd Aug 201712:37 pmRNSDirector/PDMR Shareholding
18th Aug 201712:24 pmRNSHolding(s) in Company
18th Aug 20179:00 amRNSAnnouncement of Share Buyback Programme
15th Aug 201712:19 pmRNSHolding(s) in Company
3rd Aug 20177:00 amRNSCompletion of Acquisition of MarketMakers
1st Aug 20178:46 amRNSCompletion Disposal of Home Interest
31st Jul 20177:00 amRNSTotal Voting Rights
26th Jul 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.